Microbix Announces Annual and Special Meeting Voting Results

MISSISSAUGA, Ontario, April 01, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, “Microbix” or the “Company”), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the voting results from the Annual and Special Meeting of Shareholders (the “Meeting”) which was held on March 31, 2020.

At the Meeting, 36.79% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the Meeting. Details of all resolutions that were voted upon are set out in the Management Information Circular (the “Circular”) dated February 14, 2020. The Circular is available on the Company’s website (www.microbix.com) and on SEDAR (www.sedar.com).

All of the board of directors nominees listed in the Circular were re-elected as directors of Microbix. Results of the vote were as follows:

Nominee	Votes For	% Votes For	Withheld	% Withheld
Peter M. Blecher	36,332,546	93.85%	2,378,816	6.15%
William J. Gastle	36,905,352	95.33%	1,806,010	4.67%
Martin Marino	37,024,462	95.64%	1,686,900	4.36%
Joseph D. Renner	37,024,352	95.64%	1,687,010	4.36%
Mark A. Cochran	37,022,462	95.64%	1,688,900	4.36%
Cameron Groome	36,952,854	95.46%	1,758,508	4.54%
Vaughn C. Embro-Pantalony	36,896,452	95.31%	1,814,910	4.69%

In addition, shareholders also approved a resolution re-appointing the Company’s auditors, Ernst & Young LLP, with 99.76 % of the votes cast in favour.